USCAP – 2018 Diagnostic Pathology Update. Gynecologic Pathology.

Evaluated by:A Selection of Rare Ovarian Tumors Presentation: Glenn Mccluggage, FRCPath, 28 min 21 sec David B. Kaminsky, M.D., FIAC, July 8, 2018 Original release date: October 3, 2018 Access to this course expires on: July 8, 2021 CME 3.75 | SAMs 2.75 Faculty: Glenn McCluggage, FRCPC.

EQA of malignant mesothelioma marker analyses.

Dr. Mogens Vyberg graduated in 1973, completed residencies in Anatomic and Clinical Pathology at hospitals associated with University of Copenhagen, and was board-certified 1984. Since 1988 he has been senior consultant at the Institute of Pathology, Aalborg Hospital and was appointed as professor of clinical pathology at Aalborg University in 2012. Dr. Vyberg’s main research…

Malignant mesothelioma – update on pathology and IHC.

Sisko Liisa Anttila.   Dr. Sisko Anttila, MD, PhD, is Head of the Jorvi Hospital Laboratory of Pathology at Helsinki University Hospital and HUSLAB, Espoo, Finland. Previously, between 1988 and 2007 (until 2014 part-time) she worked as chief physician and pathologist at the Finnish Institute of Occupational Health, Helsinki, Finland, and as visiting scientist at the…

Malignant mesothelioma – epidemiology and molecular biology.

Dr. Oluf Dimitri Røe.   Specialist in Oncology (Medical and Radiation Oncology) 2007 PhD Dissertation 2008 Faculty of Medicine, NTNU, Title of Thesis: Malignant mesothelioma: Virus, Biomarkers and Genes. A Translational Approach Brief Scientific profile My main research interests have been a combination of clinical and basic cancer research (translational), including biomarkers for early detection of…

EQA of lung carcinoma analyses.

Dr. Mogens Vyberg graduated in 1973, completed residencies in Anatomic and Clinical Pathology at hospitals associated with University of Copenhagen, and was board-certified 1984. Since 1988 he has been senior consultant at the Institute of Pathology, Aalborg Hospital and was appointed as professor of clinical pathology at Aalborg University in 2012. Dr. Vyberg’s main research…

2nd NordiQC Conference on Applied Immunohistochemistry.

La segunda conferencia sobre inmunohistoquímica aplicada NordiQC se llevó acabo entre los días 9 y 12 de junio de 2015 en el Europe Hall del Aalborg Congress & Culture Centre, Aalborg, Dinamarca.  A continuación se presenta el programa desarrollado con sus respectivos abstracts. idioma: Inglés. Tuesday 9th June 2015. 16:00  Registration. 18:00 Informal get-together buffet….

WHO classification of lung carcinomas 2015.

Keith Kerr has been a Consultant Pathologist in Aberdeen since 1989, after under and post-graduate training in Edinburgh. He was awarded an Honorary Chair in Pulmonary Pathology at the University of Aberdeen in 2006. His research interests include pre-neoplasia and carcinogenesis, lung tumour diagnosis and classification, and the identification of predictors of therapy response. He…

Atención Evento Cancelado. SOMLA 2018.

ATENCIÓN. IMPORTANTE. EVENTO CANCELADO. Desde la página oficial del 1er Simposio Latinoamericano de Oncología Molecular (http://www.somla.es/) se informa:   «Por razones ajenas a la organización, el Simposio de Oncología Molecular Latinoamericano (SOMLA) no va a poder realizarse en marzo 2018 como estaba previsto. Esperamos que SOMLA pueda ver la luz en un futuro y nos…

Taller de Enfermedad Inflamatoria Intestinal.

La Sociedad Argentina de Patología – SAP informa la realización del Taller de Enfermedad Inflamatoria Intestinal el día 23 de marzo de 2018 desde las 08:00 horas. El mismo se realizará en la Sede de la Sociedad Argentina de Patología sita en la calle Tte. Gral. Perón 2234 – 1º “A” de la Ciudad Autónoma…